Beta-1,4-Gal-T1 Polyclonal Antibody

B4GALT1 is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: glcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene is unique among the beta4GalT genes because it encodes an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Two transcripts, which differ only at the 5' end, with approximate lengths of 4. kb and 3. kb encode the same protein. The longer transcript encodes the type II membrane-bound, trans-Golgi resident protein involved in glycoconjugate biosynthesis. The shorter transcript encodes a protein which is cleaved to form the soluble lactose synthase.

Introducing the Beta-1,4-Gal-T1 Polyclonal Antibody, a cutting-edge scientific tool designed to facilitate advanced research in the field of glycobiology. This high-quality antibody is meticulously developed using state-of-the-art techniques, ensuring exceptional specificity and sensitivity for the detection of Beta-1,4-Gal-T1 protein expression.

The Beta-1,4-Gal-T1 Polyclonal Antibody boasts an impressive range of applications, making it an invaluable asset for scientists and researchers alike. With its ability to recognize and bind to the Beta-1,4-Gal-T1 protein, this antibody enables the investigation of various cellular processes, including glycosylation, cell adhesion, and signal transduction pathways.

Crafted with utmost precision, this polyclonal antibody exhibits exceptional performance across a diverse range of sample types, including tissue sections, cell lysates, and whole cells. Its robustness and reliability ensure consistent and reproducible results, empowering researchers to delve deeper into the intricate mechanisms underlying Beta-1,4-Gal-T1 protein function.

The Beta-1,4-Gal-T1 Polyclonal Antibody is meticulously validated through rigorous quality control measures, guaranteeing its superior performance and reliability. Its specificity is confirmed through Western blot analysis, immunohistochemistry, and immunofluorescence, providing researchers with the utmost confidence in their experimental outcomes.

With its user-friendly format, this antibody is readily accessible to both seasoned scientists and newcomers to the field. Its compatibility with various experimental techniques, such as immunoprecipitation and flow cytometry, further enhances its versatility and utility in diverse research settings.

In summary, the Beta-1,4-Gal-T1 Polyclonal Antibody represents a breakthrough in glycobiology research, offering unparalleled specificity, sensitivity, and versatility. With its exceptional performance and reliability, this antibody is poised to revolutionize the understanding of Beta-1,4-Gal-T1 protein function and its implications in various biological processes. Elevate your research endeavors with this indispensable tool and unlock new frontiers in glycobiology.